Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

CNBC’s Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 15 Stocks to Watch. In this article, we are going to take a ...

“No one ever made a dime by panicking.” These are just a few of the insights Jim Cramer has shared with investors over the course of his career. Since founding TheStreet in 1996, Cramer has ...

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 15 Stocks to Watch. In this article, we are going to take a look at where DraftKings Inc. (NASDAQ:DKNG) stands against the other ...

In this article, we will take a detailed look Jim Cramer Says These 10 Stocks Will Go Higher in Trump Presidency. In a recent program, Jim Cramer celebrated the market’s rally on Donald Trump ...

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 15 Stocks to Watch. In this article, we are going to take a look at where Pinterest, Inc. (NYSE:PINS) stands against the other ...

Jim Cramer has taken many roles in his career: hedge fund manager, TV host, best-selling author, and founder of several highly successful businesses. He’s an American television personality most ...

Jim Cramer, the host of CNBC’s “Mad Money,” lauded Salesforce.com Inc. CRM for its innovative artificial intelligence product, Agentforce, and attributed the company’s stock surge to this ...

Jim Cramer, the host of CNBC's Mad Money, has become a sort of nemesis to many GameStop shareholders. An avid critic of GameStop and other highly speculative assets, Cramer spares no opportunity ...

Jim Cramer says Travere Therapeutics is losing a "ton of money." "I don’t think Stanley Black & Decker is going to give you a discouraging forecast," Cramer says. Travere Therapeutics will ...